1. The effects of Gingko biloba, vitamin E and melatonin on bacterial translocation in thioacetamide-induced fulminant hepatic failure in rats.
- Author
-
Harputluoglu MM, Demirel U, Karadag N, Temel I, Bayraktar M, Firat S, Karahan D, Aladag M, Alan H, Ates F, Karincaoglu M, and Hilmioglu F
- Subjects
- Analysis of Variance, Animals, Antioxidants pharmacology, Biomarkers blood, Disease Models, Animal, Intestinal Mucosa metabolism, Intestines drug effects, Intestines microbiology, Intestines physiopathology, Lipid Peroxidation drug effects, Liver Failure, Acute metabolism, Liver Failure, Acute microbiology, Liver Failure, Acute mortality, Lymph Nodes microbiology, Male, Melatonin pharmacology, Mesentery, Oxidative Stress drug effects, Phytotherapy, Plant Preparations pharmacology, Rats, Spleen microbiology, Survival Rate, Thiobarbituric Acid Reactive Substances metabolism, Vitamin E pharmacology, Antioxidants therapeutic use, Bacterial Translocation drug effects, Escherichia coli physiology, Ginkgo biloba, Liver Failure, Acute chemically induced, Liver Failure, Acute drug therapy, Melatonin therapeutic use, Thioacetamide adverse effects, Vitamin E therapeutic use
- Abstract
Background and Study Aims: Bacterial translocation (BT) has been implicated in the development of infectious complications in many serious clinical conditions such as fulminant hepatic failure (FHF). We aimed to investigate the effects of Gingko biloba (GB), vitamin E (Vit E) and melatonin on intestinal oxidative damage and BT in thioacetamide (TAA)-induced FHF in rats., Materials and Methods: A total of 42 rats were divided into five groups. Group 1 (n = 8) was the control group. Group 2 (n = 10) was the TAA group, in which rats received 350 mg/kg TAA daily by the intraperitoneal (ip) route for 3 days. Oral 100 mg/kg GB per day was administered to group 3 (n = 8), oral 200 mg/kg Vit E per day to group 4 (n = 8) and ip 3 mg/kg melatonin per day to group 5 (n = 8) 48 h prior to the first TAA injection and was continued for 5 consecutive days., Results: When compared with the control group, serious hepatic and intestinal oxidative damage, increased Escherichia coli counts in ileal aspirates and high BT frequencies were observed in the TAA group (all p < 0.0001). Only GB treatment attenuated hepatic oxidative damage (p < 0.0001). There was no difference in intestinal oxidative damage, E. coli counts in ileal aspirates and BT frequency between TAA and the other antioxidant treatment groups (p > 0.05)., Conclusion: Our results suggest that intestinal oxidative damage plays a major role in the development of BT by disrupting the barrier function of intestinal mucosa.
- Published
- 2006